Beyond Discovery: Closed-Loop Systems & Defensible AI-Bio

​Event Overview

​AI has transformed biological discovery. But discovery is getting cheaper, so where does value go next?

​This panel explores the harder questions: defensibility, closed-loop systems, real-world biological interfaces, and what it actually takes to build enduring AI-native companies.

​On the table:

• ​Are current AI-bio companies building real moats?

• ​Will foundation models commoditize?

• ​Has the field over-indexed on therapeutics?

• ​What infrastructure is still missing?

​No recycled drug discovery narratives. Just founders, researchers, engineers, and investors working at the frontier — and willing to disagree.

​Agenda
5:30-6:15pm: Arrival & Networking
6:15-6:20pm: Opening Remarks
6:20-6:30pm: Intro from BGA & Bits in Bio
6:30-7:20pm: Panel Discussion
7:20-7:30pm: Audience Q&A
7:30-8:00pm: Networking

​🗓 Thursday, August 13 · 5:30–7:30pm
📍 Berkeley Gateway Accelerator, Berkeley CA
Hosted by BGA, DiagnoBacs & Bits in Bio